As of the latest SEC filings, Alto Neuroscience, Inc. (ANRO) is held by 44 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $19,687,556.88 in market value, representing a significant portion of its portfolio.
Funds holding Alto Neuroscience, Inc. (ANRO)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- ANRO
- CIK:
- 0001999480
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $19,687,556.88 | 875,781 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $6,796,221.04 | 302,323 | Mar 31, 2026 | May 28, 2026 |
|
FBTDX
Franklin Biotechnology Discovery Fund
|
MF | Franklin Templeton | 0.59% | $6,163,660.30 | 240,205 | Apr 30, 2026 | Jun 24, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.06% | $6,030,934.40 | 268,280 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.06% | $4,780,978.96 | 212,677 | Mar 31, 2026 | May 28, 2026 |
|
FBTDX
Franklin Biotechnology Discovery Fund
|
MF | Franklin Templeton | 0.41% | $4,235,696.20 | 165,070 | Apr 30, 2026 | Jun 24, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.01% | $2,758,687.14 | 140,106 | Feb 28, 2026 | Apr 24, 2026 |
|
XPH
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF
|
ETF | State Street (SPDR) | 0.54% | $1,647,514.24 | 73,288 | Mar 31, 2026 | May 28, 2026 |
|
IWC
iShares Micro-Cap ETF
|
ETF | BlackRock / iShares | 0.11% | $1,316,069.12 | 58,544 | Mar 31, 2026 | May 28, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $958,253.23 | 48,667 | Feb 28, 2026 | Apr 24, 2026 |
|
PSIL
AdvisorShares Psychedelics ETF
|
ETF | Independent / Boutique | 4.55% | $922,197.04 | 41,023 | Mar 31, 2026 | May 21, 2026 |
|
ITOT
iShares Core S&P Total U.S. Stock Market ETF
|
ETF | BlackRock / iShares | 0.00% | $823,622.24 | 36,638 | Mar 31, 2026 | May 28, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $762,022.69 | 38,701 | Feb 28, 2026 | Apr 24, 2026 |
|
BRSIX
Ultra-Small Company Market Fund
|
MF | Independent / Boutique | 0.46% | $562,000.00 | 25,000 | Mar 31, 2026 | May 21, 2026 |
|
SBIO
ALPS Medical Breakthroughs ETF
|
ETF | Independent / Boutique | 0.39% | $545,176.72 | 27,688 | Feb 28, 2026 | Apr 29, 2026 |
|
BRUSX
Ultra-Small Company Fund
|
MF | Independent / Boutique | 0.62% | $529,471.44 | 23,553 | Mar 31, 2026 | May 21, 2026 |
|
SWTSX
Schwab Total Stock Market Index Fund
|
MF | Charles Schwab | 0.00% | $421,260.22 | 16,417 | Apr 30, 2026 | Jun 25, 2026 |
|
VBINX
VANGUARD BALANCED INDEX FUND
|
MF | Vanguard | 0.00% | $356,847.52 | 15,874 | Mar 31, 2026 | May 28, 2026 |
|
DFSTX
U.S. SMALL CAP PORTFOLIO
|
MF | Dimensional Fund Advisors | 0.00% | $320,313.78 | 12,483 | Apr 30, 2026 | Jun 24, 2026 |
|
VITNX
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND
|
MF | Vanguard | 0.00% | $289,340.08 | 12,871 | Mar 31, 2026 | May 28, 2026 |
|
DFQTX
U.S. CORE EQUITY 2 PORTFOLIO
|
MF | Dimensional Fund Advisors | 0.00% | $280,130.22 | 10,917 | Apr 30, 2026 | Jun 24, 2026 |
|
PEXMX
T. Rowe Price Extended Equity Market Index Fund
|
MF | T. Rowe Price | 0.03% | $270,794.08 | 12,046 | Mar 31, 2026 | May 28, 2026 |
|
AVSC
Avantis U.S. Small Cap Equity ETF
|
ETF | American Century | 0.01% | $201,153.04 | 10,216 | Feb 28, 2026 | Apr 29, 2026 |
|
GARTX
Goldman Sachs Absolute Return Tracker Fund
|
MF | Goldman Sachs | 0.00% | $188,135.12 | 8,369 | Mar 31, 2026 | May 26, 2026 |
|
NSGRX
Small Cap Core Fund
|
MF | Independent / Boutique | 0.04% | $151,627.60 | 6,745 | Mar 31, 2026 | May 28, 2026 |
Advertisement (320x50)